Latest Breaking News On - Scare med - Page 4 : comparemela.com

Asep Inc Announces Ground-breaking A I Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies

/PRNewswire/ - Asep Medical Holdings Inc. ("Asep Inc." or the "Company") (CSE: ASEP) (OTCQB: SEPSF) (FSE: JJ8) announces the ground-breaking use of artificial.

British columbiaUnited kingdomGv cohen freueG cohen freueRobertew hancockDevan haneyAsep medical incSepset biosciences incAsep incInnovations incHoldings incSafecoat medical incHancock labAsep medical holdings incUniversity of british columbiaMedical holdings

Asep Inc Announces Ground-breaking A I Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies

Asep Inc Announces Ground-breaking A I Technology for Rapid Identification of Severe Sepsis and Improved Superbug Therapies
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

British columbiaUnited kingdomRobertew hancockGv cohen freueDevan haneyG cohen freueAsep incAsep medical holdings incSafecoat medical incUniversity of british columbiaAsep medical incSepset biosciences incHancock labHoldings incInnovations incMedical holdings

Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with cardiac arrest: a comparative meta-analysis and trial sequential analysis

Extracorporeal cardiopulmonary resuscitation versus conventional cardiopulmonary resuscitation in adults with cardiac arrest: a comparative meta-analysis and trial sequential analysis
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South koreaJapan generalJ thorac cardiovascClin neurosciColl cardiolAl falasiNational registry of cardiopulmonary resuscitationExtracorporeal life support organizationExtracorporeal life support organization registryEvid based ment healthArrest registryCrit careNational registryIntensive care socEnglj medClin epidemiol

Low versus standard calorie and protein feeding in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group trial (NUTRIREA-3)

Compared with standard calorie and protein targets, early calorie and protein restriction did not decrease mortality but was associated with faster recovery and fewer complications.

United statesReintam blaserActa anaesthesiol scandClin nutrClinical trials networkSociety of critical care medicineAmerican society for parenteralScare medCritical care medicineAmerican societyEnteral nutritionAnaesthesiol scandEnglj med

Intravenous ravulizumab in mechanically ventilated patients hospitalised with severe COVID-19: a phase 3, multicentre, open-label, randomised controlled trial

Addition of ravulizumab to BSC did not improve survival or other secondary outcomes. Safety findings were consistent with the known safety profile of ravulizumab in its approved indications. Despite the lack of efficacy, the study adds value for future research into complement therapeutics in critical illnesses by showing that C5 inhibition can be accomplished in severely ill patients.

United statesUnited kingdomEteläuomen läiJonathan monteleone alexionDassule alexionSenhwa biosciencesMary greenacreMark ma alexionArshad mujeebuddin alexionStephan ortizAlanna mceneny alexionChildren discovery instituteAmerican society of clinical investigationYork heart associationLife foundationHealth survey physical component summary